These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 11990286)

  • 1. Measuring the cost of inhaled anaesthetics.
    Zych Z
    Br J Anaesth; 2002 Mar; 88(3):454; author reply 454. PubMed ID: 11990286
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-flow definition, concentration and cost of anaesthetics.
    Couto da Silva JM
    Br J Anaesth; 2000 Nov; 85(5):804-5. PubMed ID: 11094605
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost minimisation and cost effectiveness in anaesthesia for total hip replacement surgery, in Belgium? A study comparing three general anaesthesia techniques.
    Demeere JL; Merckx Ch; Demeere N
    Acta Anaesthesiol Belg; 2006; 57(2):145-51. PubMed ID: 16916184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhalation anesthetics in financial contexts].
    Bauer M; Bach A; Martin E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Jun; 36(6):373-7. PubMed ID: 11475633
    [No Abstract]   [Full Text] [Related]  

  • 5. Halothane, isoflurane and sevoflurane in pediatric anesthesia: can we decrease costs without increasing adverse events?
    Nava-Ocampo AA; Alarcón-Almanza JM; Moyao-García D; Ramírez-Mora JC; Salmerón J
    Paediatr Anaesth; 2004 Oct; 14(10):891-2. PubMed ID: 15385025
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost of volatile anaesthetic agents.
    Daniel M
    Br J Anaesth; 1996 Sep; 77(3):437. PubMed ID: 8949832
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the costs of anesthesia gases.
    Appl Cardiopulm Pathophysiol; 1995; 5 Suppl 2():97-9. PubMed ID: 10150779
    [No Abstract]   [Full Text] [Related]  

  • 8. Special aspects of pharmacokinetics of inhalation anesthesia.
    Hendrickx JF; De Wolf A
    Handb Exp Pharmacol; 2008; (182):159-86. PubMed ID: 18175091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is halothane the end of an era?
    Splinter W
    Anesth Analg; 2003 Aug; 97(2):602. PubMed ID: 12873963
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhaled anesthetics and the role of the pharmacist in today's surgical environment. Introduction.
    Golembiewski J
    Am J Health Syst Pharm; 2004 Oct; 61 Suppl 4():S2-3. PubMed ID: 15532142
    [No Abstract]   [Full Text] [Related]  

  • 11. Temperature coefficients of the solubilities of inhaled anaesthetics.
    Alott PR; Flook V
    Br J Anaesth; 2000 Jun; 84(6):830. PubMed ID: 10895780
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of fresh gas flow on the amount of sevoflurane vaporized during 1 minimum alveolar concentration anaesthesia for day surgery: a clinical study.
    Ekbom K; Assareh H; Anderson RE; Jakobsson JG
    Acta Anaesthesiol Scand; 2007 Mar; 51(3):290-3. PubMed ID: 17250746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and costs of 3 anesthetic regimens in the prevention of postoperative nausea and vomiting.
    Purhonen S; Koski EM; Niskanen M; Hynynen M
    J Clin Anesth; 2006 Feb; 18(1):41-5. PubMed ID: 16517331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low dose inhaled anaesthetic agents on the ventilatory response to carbon dioxide in humans: a quantitative review.
    Pandit JJ
    Anaesthesia; 2005 May; 60(5):461-9. PubMed ID: 15819767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and economic considerations in the use of inhaled anesthesia from the perspective of health-system pharmacists and anesthesiologists. Introduction.
    Meyer T
    Am J Health Syst Pharm; 2010 Apr; 67(8 Suppl 4):S2-3. PubMed ID: 20360570
    [No Abstract]   [Full Text] [Related]  

  • 16. Volatile anaesthetics and net zero: a quantitative approach for spending money effectively.
    Kalmar AF; Mulier H; Rex S
    Anaesthesia; 2024 Jun; 79(6):665-666. PubMed ID: 38462792
    [No Abstract]   [Full Text] [Related]  

  • 17. Economic evaluation of inhaled nitric oxide in preterm infants undergoing mechanical ventilation.
    Zupancic JA; Hibbs AM; Palermo L; Truog WE; Cnaan A; Black DM; Ballard PL; Wadlinger SR; Ballard RA;
    Pediatrics; 2009 Nov; 124(5):1325-32. PubMed ID: 19841125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of inhaled corticosteroids for chronic obstructive pulmonary disease according to disease severity.
    Sin DD; Golmohammadi K; Jacobs P
    Am J Med; 2004 Mar; 116(5):325-31. PubMed ID: 14984818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and potential cost/benefit of routine isoflurane sedation using an anesthetic-conserving device: a prospective observational study.
    L'her E; Dy L; Pili R; Prat G; Tonnelier JM; Lefevre M; Renault A; Boles JM
    Respir Care; 2008 Oct; 53(10):1295-303. PubMed ID: 18811990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenon in intensive care.
    Marx T
    Crit Care Med; 2003 Oct; 31(10):2556-7. PubMed ID: 14530769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.